Cross-talks between HER2 and other cell membrane receptors such as estrogen receptor (ER), IGFR, and EGFR may initiate downstream signaling through MAPK and PI-3 kinase pathways in breast cancer cells [82], suggesting the importance to determine the genes crucial in the cross-talks for therapeutic purpose. The gene discussed is ERBB2; the disease is breast carcinoma.